Introduction
Hepatocellular carcinoma (HCC) is the third leading cause of death from malignancy worldwide, and hepatitis B and C and associated liver cirrhosis represent major risk factors for HCC development. T cell response has a vital role during hepatitis virus infection.
Myriad data support the role of inflammation as a key player in HCC development (1) . The inflammation can be triggered by tissue damage, infection and toxin. Our previous data showed that gut-derived LPS promote the inflammation during HCC development by activating Toll-like receptor 4 expressed on myeloid-derived cells (2) . However, the effects of gut-derived LPS and Toll-like receptor 4 (TLR4) on other types of liver injury models are yet to be studied.
Con A-induced hepatitis is a well-known experimental murine model with significantly elevated levels of transaminase as well as severe liver injury that can mimic many kinds of human T cell-mediated hepatitis, such as virus hepatitis and autoimmune hepatitis (3) (4) (5) . In Con A-mediated hepatitis model, activated T cells release a series of cytokines. Different cytokines can be categorized as T helper 1 (Th1) and T helper 2 (Th2) associated cytokines by their biological function. Studies have illustrated that Th1 associated cytokines such as and IFN-γ are dominant factors inducing the development of Th1 cells (6) . Conversely, IL-4 production directs the development of a Th2 response (7) . Th1/Th2 differentiation of T cells is largely dependent on the balance of GATA-3 (8) and T-bet (9) . The balance of Th1 and Th2 associated cytokines exerts a crucial role in normal immunoregulation and neoplastic outcome.
Emerging evidence suggests a strong interaction between the gut microbiota and human liver diseases (10;11) . Receiving ∼70% of its blood supply from the intestine through the portal circulation, the liver is the first line of defense against gut-derived antigens (11) . In order to cope with these latent systemic pathogens the liver contains a large number of resident immune cells such as macrophages, natural killer cells, dendritic cells, T and B lymphocytes (12) . When normal liver physiology is disrupted and inflammatory cells are activated, gut-derived factors likely augment or exacerbate certain liver diseases, leading to enhanced tissue damage and propagation of inflammation via activation of TLR-signaling pathways (13) . The critical role of gut-derived endotoxin as a cofactor in acute and chronic liver diseases, both experimental and clinical, was already established more than 30-40 years ago (14) . Our previous study also demonstrated that the endotoxin/TLR4 regulates the survival and proliferation of hepatocytes and their pre-neoplastic derivatives during chemically induced hepatocarcinogenesis (2) .
Toll like receptors (TLRs) recognize pathogen-associated molecular patterns and activate signaling pathways that lead to the induction of innate immune and inflammatory genes (15) .
In addition, there is accumulating evidence that TLRs contribute significantly to the activation of adaptive immune responses such as dendritic cell maturation and T-and B-cell responses， specially, the TH1-dependent immune responses (16) . TLR4 is an important member of TLRs, which could sense endotoxin and activate transcription factors that initiate innate immunity.
TLR4 was also expressed on T lymphocyte, playing a vital role in adaptive immunity. Recent studies have demonstrated the contribution of TLR4 signaling to the trapping of CD8 + T cells within the murine liver (17 
Materials and Methods

Animals
Male wild type (wt; C57BL/10ScSnJ), and TLR4 deficient (TLR4-/-; C57BL/10ScNJ) mice were obtained from the Model Animal Research Center of Nanjing University, Nanjing, China. Male C57BL/6 mice (6-8 weeks old, weighing 18-22 g) and NOD/SCID mice were obtained from the Shanghai Experimental Center, Chinese Science Academy, Shanghai, and maintained at an animal facility under pathogen-free conditions. All animals received humane care according to the criteria outlined in the ''Guide for the Care and Use of Laboratory 
Isolation and Culture of CD4 + cells
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Results
Depletion of gut-derived LPS alleviates Con A-induced liver injury in TLR4 intact mice
Our previous study has shown that gut-derived endotoxin can promote DEN-induced liver injury and hepatocarcinogenesis (2), so we conjecture that gut-derived endotoxin may also impose a serious impact on other types of liver injury. To address this question, we chose the widely-used Con A-induced hepatitis animal model, which mimics many kinds of human T cell-mediated hepatitis. As shown in the Fig.1A , the serum levels of LPS were markedly elevated 6, 20 hours after Con A administration accompanied with severe liver inflammation and tissue injury, suggesting that serum endotoxin may be a critical cofactor in Con A-induced liver injury.
We next investigated whether circulating LPS exacerbates Con A-induced hepatitis. Mice were treated with a cocktail of nonabsorbable broad-spectrum antibiotics for four weeks (19) and then injected with Con A. Mice receiving this cocktail regimen showed reduced serum levels of LPS (Fig.1B ) and significant decrease in serum ALT and AST levels ( Fig.1C) , indicating reduced liver damage in the antibiotics-treated mice than controls. This was confirmed by H&E and TUNEL staining, which showed reduced apoptosis and necrosis in the liver of antibiotics-treated mice (Fig.1D , E). Reduced apoptosis was further confirmed by processing the pro-caspase-3 and PARP to the cleaved active form (Fig.1F) . Moreover, compared with control mice, the expression of anti-apoptotic protein Mcl-1 was higher, while the pro-apoptotic protein Bax was lower in antibiotics-treated mice (Fig.1F ). Both Erk1 and Erk2 have important roles in regulating cell proliferation and cell differentiation (20) . We found that the phosphorylation of Erk1/2 was significantly higher in antibiotics-treated mice (innate receptor of LPS)-deficient mice, deletion of gut-derived LPS had no protective roles in Con A-induced hepatitis, as there was no significant difference in serum ALT levels between the antibiotics treated and untreated group (Fig.1H ).
In conclusion, these data definitely indicated that the gut-derived LPS promote Con A induced hepatitis through TLR4 and may regulate the apoptotic pathway in the parenchymal cells.
Depletion of gut-derived LPS suppresses T cell infiltration and CD4 + T cell activation
Next we analyzed the key pathways that were involved in Con A-induced injury. 
Deletion of gut-derived LPS suppresses secretion of Th1-associated cytokines
Immune cells activated by Con A synthesize and secrete a series of inflammatory cytokines and these cytokines are vital components of Con A-induced liver injury (3;4). Using ELISA, expression of key T helper 1 cytokines such as TNF-α, IFN-γ, IL-12, IL-2 and IL-6, as well as T helper 2-associated cytokines IL-10 in the two groups were assessed. Fig.2C shows that there is no difference in baseline of Th1-associated cytokines and Th2-associated cytokines at 0 hour; but at 3, 6 and 20 hours after Con A administration, the levels of Th1 cytokines in antibiotics-treated mice were much than in controls. Interestingly, Th2-associated cytokines IL-10 were much higher in antibiotics-treated mice than control mice (Fig.2D ). These data suggest that LPS may augment the Th1 response while inhibit the Th2 response to promote Con A-induced liver injury.
Exogenous LPS significantly aggravates Con A-induced liver injury
To further evaluate the contribution of LPS to the pathogenesis of Con A-induced liver injury, mice were co-injected with LPS and a low dose of Con A (10mg/kg) or Con A alone.
As shown in Fig.3A , the ALT levels of the LPS + Con A-injected group were much higher than that of Con A group. Meanwhile, the proportion of activated CD4 + cells in mice treated with LPS+Con A were higher than the mice injected with Con A or exogenous LPS(80.75%VS 62.04% VS 5.30%)(Fig3B). The Th1 cytokines such as IL-2, TNF-α, IFN-γ and IL-12 were also elevated in the LPS+Con A group (Fig.3C) . To investigate the possible mechanisms of these findings, we evaluated the expression of T-bet (an important regulator of Th1 differentiation) by quantitative PCR. As shown in Fig.3D , the expression of T-bet was significantly increased in Con A+LPS-treated mice compared with Con A-treated mice 3
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TLR4 deficiency greatly attenuates Con A-induced liver injury
LPS exerts its effects primarily through its innate receptor TLR4, we then assessed the effect of TLR4 deficiency on Con A-induced hepatitis. Wild-type (wt) mice and TLR4
knockout (TLR4 -/-) mice were injected with Con A intravenously and sacrificed 0, 6 and 20 hours thereafter. Analysis of liver histopathology revealed blunted inflammation and tissue injury in TLR4 -/-mice compared with wt mice (Fig.4A ). This was confirmed by serum ALT and AST levels (Fig.4B ). TUNEL staining showed that more apoptotic cells were present in wt livers compared to livers from TLR4 -/-mice (Fig.4C ). This was further confirmed by the activation of caspase-3 and PARP (cleavage form of caspase 3 and PARP) (Fig.4D) . Moreover, as shown in Fig.4E , TLR4 deficiency protected mice from a lethal dose of Con A: 66.7% of TLR4 wt mice died 9 hours after Con A injection, whereas 87.5% of TLR4 -/-mice survived within 24 hours.
Besides, similar to the finding in the antibiotics-treated mice, Mcl-1 was much higher whereas Bax was much lower in TLR4 -/-mice at 6 and 20 hours after Con A injection; the phosphorylation of Erk1/2 was significantly higher in TLR4 -/-mice (Fig.4F ) at 1 and 3 hours following Con A injection. Taken together, these data demonstrate that TLR4 deficiency protect the mouse from Con A-induced hepatitis.
Deletion of TLR4 suppresses T cell infiltration and CD4 + T cell activation following Con
A administration
To further verify TLR4-dependent steps to aggravate Con A-induced hepatitis, we
+ T cell pool, in which more than 95% of splenic cells were positive for CD4 (Fig.5E ). These data indicated that LPS alone have little effect to activate T lymphocytes, but it could promote Con A-induced CD4 + T lymphocytes activation effectively, suggesting LPS may have a direct role in the T cell activation.
TLR4 ablation in bone marrow-derived cells alleviate Con A-induced liver injury
As TLR4 is expressed both on myeloid-derived cells and parenchymal cells in the liver, the difference of liver injury between wt and TLR4 -/-mice might be caused by a bone marrow-derived cell or a resident liver cell such as hepatocytes, endothelial or stellate cells.
To rule out these possibilities, we performed bone marrow transplantation experiments in the TLR4 knockout and wild type mice. Five weeks later, the chimeric mice were injected with 
TLR4 deletion significantly reduces the production of Th1 cytokines
With ELISA, expression of T helper 1 cytokines such as TNF-α, IFN-γ, IL-12, IL-2 and IL-6, as well as T helper 2-associated cytokines IL-10, was assessed at 0, 3, 6 and 20 hours after Con A injection. Fig. 6D shows that there is no difference in baseline of Th1-associated cytokines and Th2-associated cytokines before Con A injection; however, after Con A administration, wt mice exhibited much higher levels of Th1 cytokines compared with TLR4 -/-mice. Interestingly, Th2-associated cytokine IL-10 were much higher in TLR4 -/-mice in contrast to wt mice (Fig.6D ).
We also evaluated the expression of T-bet by quantitative PCR. As shown in Fig.6E , T-bet expression showed no difference between wt and TLR4 -/-animals before Con A administration; however, 1 and 3 hours after Con A injection, expression of T-bet was significantly increased in wt mice compared with TLR4 -/-mice.
Taken together, our results demonstrate a TLR4-related enhancement of key cytokines of the Th1 response, indicating that unusually prolonged exposure to these cytokines might exacerbate T cell-mediated hepatitis. However, TLR4 deletion could significantly increase the production of IL-10 which can lighten Con A-induced liver injury.
Previous studies have identified that significant increases in pro-inflammatory cytokine expression aggravate the induction of apoptosis (22) demonstrate that the expression of perforin was much higher in wt mice compared to the TLR4 -/-mice (Fig.6F) . Furthermore, the levels of granzyme B were significantly higher in wt mice than in TLR4 -/-mice particularly 20 hours post Con A injection (Fig.6F) , indicating that the perforin/ granzyme B pathway is a possible mechanism of augmenting Con A-induced liver injury by TLR4.
Discussion
Because of the anatomic links to the gut, there is a potential interrelation between the gut antigens, gut microbiota products (specifically endotoxin) and liver diseases. Although liver is constantly exposed to microbial products from the enteric microflora, no obvious inflammation occurs in the healthy liver. However, when normal liver physiology is disrupted and inflammatory cells are activated, gut-derived factors likely augment or exacerbate certain liver diseases leading to enhanced tissue damage and propagation of inflammation. Activation of innate immunity, specifically TLR4 signaling, has emerged as a central component of the liver's inflammatory response to gut bacteria under pathologic conditions (13;27) . Abundant data demonstrate that TLR4 ligand, endotoxin, is elevated in experimental models of hepatic fibrosis (28) and patients with chronic liver diseases (29;30) . We have now observed that serum endotoxin levels were elevated in an immune-mediated liver injury model. This endotoxin may result from: (1) decreased clearance of LPS: hepatocyte damage and reticuloendothelial system (mainly the Kupffer cells) dysfunction induced by Con A; (2) increased gut permeability: the detoxification ability of liver is reduced because of the liver damage. Indeed, gut barrier dysfunction leading to elevated intestinal permeability is also considered the main cause of endotoxemia in alcoholic liver disease (31) and has an important role in LPS/GalN-induced fulminant hepatitis (32) ; (3) 
induced by DEN, TLR4 activation (by LPS, et al) on hepatocytes could protect them from apoptosis by induction of anti-apoptotic proteins, such as Bcl-xl and A20. TLR4 deficiency therefore ablated the protective effects of both LPS and endogenous ligands on hepatocytes, thus leading to more severe liver damage. However, in the Con A model, the BMT experiment showed that TLR4 expressed on myeloid cells played major roles in liver damage. On the other hand, Con A is a more potent inducer of liver damage than DEN: Con A-hepatitis is a fulminant hepatitis, the ConA treated mice usually died with several hours; while the DEN was a milder liver poison, and does not lead to death at the dosage we used (100mg/kg).
T lymphocyte-associated cytokine production has previously been shown to be critical for the injury response. Th1 and Th2 cytokines are antagonistic in activity and their balance and regulation is crucial for the immune response (6;7). However, in pathologic conditions such as allergic and autoimmune diseases, polarized Th1 and Th2 responses are found and believed to be critical to the outcome of these conditions (8) . Here we found that exogenous LPS promotes Th1 cytokine production induced by Con A through TLR4, whereas reduction of LPS using antibiotics or the absence of TLR4 reinforces the expression of Th2 cytokines.
T-bet is a powerful transcription factor involved in Th1 development (9) . Our results suggested that LPS promote Con A-induced expression of T-bet through TLR4. The Th1 cytokines, particularly TNF-α，are important cytotoxic mediators. It's conceivable that the elevated Th1 associated cytokines promote Con A-induced cellular immunity and aggravate liver tissue damage. Moreover, T lymphocyte cytotoxicity has been proposed as mechanism of apoptosis (25;26) . An important pathway in T lymphocyte-mediated cytotoxicity is the granule exocytosis of perforin/granzymes (26) . In the current study, we found that TLR4
